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Two simple, selective, and rapid spectrophotometric methods are described for the determination of mycophenolate mofetil
(MPM) in pure form and in tablets. Both methods are based on charge-transfer complexation reaction of MPM with p-chloranilic
acid(p-CA)or2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ)indioxane-acetonitrile mediumresultingincolouredproduct
measurableat520nm(p-CA)or580nm(DDQ).Beer’slawisobeyedovertheconcentrationrangesof40–400and12–120μgmL −1
MPM for p-CA and DDQ, respectively, with correlation coeﬃcients (r) of 0.9995 and 0.9947. The apparent molar absorptivity
values are calculated to be 1.06 × 103 and 3.87 × 103 Lmol −1 cm−1, respectively, and the corresponding Sandell’s sensitivities are
0.4106 and 0.1119μgcm −1. The limits of detection (LOD) and quantiﬁcation (LOQ) are also reported for both methods. The
described methods were successfully applied to the determination of MPM in tablets. Statistical comparison of the results with
those of the reference method showed excellent agreement. No interference was observed from the common excipients present
in tablets. Both methods were validated statistically for accuracy and precision. The accuracy and reliability of the methods were
further ascertained by recovery studies via standard addition procedure.
1.Introduction
Mycophenolate mofetil (MPM), chemically known as 2-
morpholinoethyl (E)-6-(1,3-dihydro-4-hydroxy-6-methoxy-
7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate,
is an immunosuppressive agent, inosine monophosphate de-
hydrogenase (IMPDH) inhibitor. MPM is rapidly absorbed
following oral administration and hydrolysed to its metabo-
lite, mycophenolic acid (MPA). MPA as a newer immuno-
suppressant is mainly used in acute rejection treatment [1].
A survey of literature revealed that a few chromato-
graphic methods have been reported to quantify mycophe-
nolic acid (MPA) and its degradation products in body
ﬂuids [2–6]. Sugioka et al. [7] have developed high-perform-
ance liquid chromatographic (HPLC) method for the deter-
mination of MPM in biological samples including rat and
human body ﬂuids. However, there are only three reports on
the determination of MPM in pharmaceuticals. Protic et al.
[8] have applied HPLC for the simultaneous determination
of MPM and its degradation product MPA in dosage form.
AnHPLCmethodfordetectingdissolutionofMPMcapsules
and assay of the drug has been developed by Yang and He
[9] .T h em e t h o di sr e p o r t e dt ob ea p p l i c a b l eo v e rac o n -
centration range 62−621μgmL −1 MPM. Recently, two UV-
spectrophotometric methods to determine MPM in 5−
40μgmL −1 range have been reported by Verma et al. [10].
TheabsorbanceofMPMineither0.1MHCloracetatebuﬀer
of pH 4.9 was measured at 250nm.
Molecular interactions between electron donors and ac-
ceptors are generally associated with the formation of in-
tensely colored charge-transfer (CT) complexes which ab-
sorb radiation in the visible region [11, 12]. Substituted
quinones such as 2,3-dichloro-5,6-dicyano-1,4-benzoquin-
one (DDQ) and p-chloranilic acid (p-CA) have been used
as π-acceptors with various donors to form C-T complexes
and radicals. Applications of p-CA and DDQ for the deter-
mination of a number of pharmaceutical compounds [13–
18] have recently been described.
To the best of our knowledge, no visible spectrophoto-
metric method is available for the quantiﬁcation of MPM2 Journal of Analytical Methods in Chemistry
in pharmaceuticals. This paper describes two visible spec-
trophotometric methods based on the interaction between
the amine moiety of MPM as the n-donor and p-CA as
well as DDQ as π-acceptors resulting in the formation of
intenselycolouredC-Tcomplexes.Theselectivity,sensitivity,
accuracy, and precision of the developed methods, and their
application to the determination of MPM in tablets were
studied.
2. Experimental
2.1. Apparatus. All absorption measurements were made
using a Systronics model 106 digital spectrophotometer
(Systronics Ltd., Ahmadabad, India) with 1cm path length
quartz cells.
2.2. Materials. Pharmaceutical grade MPM was procured
from Apotex Pvt. Ltd., Bangalore, India, and certiﬁed to
be 99.5% pure. It was used without further puriﬁcation.
CellCept 500 (Roche, Mumbai, India) tablets were pur-
chased from local market. 1,4-Dioxane and acetonitrile
(spectroscopic grade) were purchased from Merck, Mumbai,
India. Distilled water was used wherever required. All other
chemicals used were of analytical reagent grade.
2.3. Reagents. A 0.5% p-chloranilic acid (p-CA) and 0.25%
2,3-dichloro-5,6-dicyano benzoquinone (DDQ) (both from
S. D. Fine Chem. Ltd., Mumbai), respectively, were prepared
freshly in 1,4-dioxane.
For p-CA method, a 500μgmL −1 MPM stock solution
was prepared by dissolving 50mg of pure drug in acetonitrile
in a 100mL volumetric ﬂask, the solution was diluted to
the mark with the same solvent, and the above 500μgmL −1
MPM stock solution was diluted with acetonitrile to get
150μgmL −1 and used for the assay in DDQ method.
2.4. Assay Procedure
2.4.1. p-CA Method. Varying aliquots of standard MPM
solution (0.4–4.0mL of 500μgmL −1) equivalent to 40–
400μgmL −1 were accurately transferred into a series of 5mL
calibrated ﬂasks and the total volume in each ﬂask was
brought to 4mL by adding acetonitrile. After the addition of
1mL of 0.5% p-CA solution, the content was mixed well and
the absorbance was measured after 5min at 520nm against
a reagent blank similarly prepared without adding MPM
solution.
2.4.2. DDQ Method. Into a series of 5mL calibration
ﬂasks, aliquots (0.2–4.0mL) of standard MPM solution
(150μgmL −1) equivalent to 6–120μgmL −1 MPM were
accurately transferred, and to each ﬂask 1mL of 0.25% DDQ
solution was added and mixed. After 5min, the absorbance
of the purple coloured was measured at 580nm against the
reference blank similarly prepared without drug.
Standard graph was prepared by plotting the absorbance
versus MPM concentration, and the concentration of the
unknown was read from the calibration graph or computed
from the respective regression equation derived using the
absorbance-concentration data.
2.4.3. Procedure for Commercial Dosage Forms. Twenty
tablets were weighed and pulverized. An amount of tablet
powder equivalent to 50mg MPM was transferred into a
100mL volumetric ﬂask and about 70mL of acetonitrile
was added to the ﬂask. The content was shaken well for
20min and diluted to the mark with the same solvent. The
resulting solution was ﬁltered through Whatmann number
42 ﬁlter paper and used for the assay by following the general
procedure described for p-CA method. This tablet extract
(500μgmL −1) was diluted to 150μgmL −1 with acetonitrile
andasuitablealiquotwasusedfortheassayinDDQmethod.
2.4.4. Procedure for the Analysis of Placebo Blank and Syn-
thetic Mixture. A placebo blank containing starch (15mg),
acacia (10mg), sodium citrate (10mg), hydroxyl cellulose
(10mg), magnesium stearate (10mg), talc (15mg), and
sodium alginate (10mg) was prepared by mixing all the
components into a homogeneous mixture. A 5mg of the
placebo blank was accurately weighed and its solution was
prepared as described under “Procedure for commercial
dosage forms” and then subjected to analysis following the
general procedures.
An accurately weighed 100mg of MPM was added to
200mg of placebo blank and homogenized. An amount of
synthetic mixture containing 50mg MPM was accurately
weighed and transferred into a 100mL volumetric ﬂask and
t h ee x t r a c te q u i v a l e n tt o5 0 0μgmL −1 MPM was prepared as
described under “Procedure for commercial dosage forms”
and used in p-CA method. Required volume of the previous
extract was diluted to 150μgmL −1 in MPM with acetonitrile
and used for DDQ method following the general recom-
mended procedure.
3. Results and Discussion
3.1. Spectral Characteristics and Reaction Mechanism. The
charge transfer complex forming reactions occur when
π-acceptors react with the basic nitrogenous compounds
which act as n-donors. Charge-transfer complex formation
is characterized by electronic transition(s) to an excited state
in which there is a partial transfer of electronic charge
from the donor to the acceptor moiety. As a result, the
excitation energy of this resonance occurs very frequently
in the visible region of the electromagnetic spectrum. This
produces usually intense-coloured characteristics for these
complexes. Therefore, MPM, a nitrogenous base acting as
n-donor, was made to react with p-CA and DDQ (π-
acceptors) to produce a coloured charge transfer complexes
in 1,4-dioxane-acetonitrile solvent system according to the
following equation:
MPM+A  MPM-A
C-T complex
 MPM
•+ +A
•−
Radical anion
(1)
In the p-CA method, MPM reacts with the reagent
and gives a red chromogen that exhibits a strong absorp-
tion maximum at 520nm in dioxane-acetonitrile mediumJournal of Analytical Methods in Chemistry 3
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Figure 1: Absorption spectra of (a) MPM-p-CA C-T complex and its blank and (b) MPM-DDQ C-T complex and its blank.
(Figure 1(a)). This can be attributed to the formation of
charge-transfer complex between MPM and p-CA followed
by the formation of radical ions which probably was due
to the dissociation of the original (MPM-p-CA) complex
promoted by the high ionizing power of the acetonitrile
solvent [19].
In the second method, the interaction of MPM with
DDQ in dioxane-acetonitrile at room temperature gave a
red-colored chromogen with strong absorption maxima at
460, 540, and 580nm due to the formation of the free radical
anion [20] and the wavelength 580 was selected for further
studiesbecauseofhighersampleabsorbanceandlowerblank
absorbance readings (Figure 1(b)).
3.2. Optimization of Reaction Conditions. Optimum condi-
tions were established by measuring the absorbance of C-T
complexes at 520 and 580nm, for p-CA and DDQ method,
respectively, by varying one and ﬁxing other parameters.
3.2.1. Eﬀect of Reagent Concentration. To establish optimum
concentrations of the reagents for the sensitive and rapid
formation of the MPM charge transfer complexes, the drug
(MPM) was allowed to react with diﬀerent volumes of
the reagents (0.5–2.5mL of 0.5% p-CA and 0.5–3mL of
0.25% DDQ). In both the cases, maximum and minimum
absorbance values were obtained for sample and blank, re-
spectively, only when 1mL of the reagent was used. There-
fore, 1mL of each reagent in a total volume of 5mL was used
throughout the investigation (Figure 2).
3.2.2. Eﬀect of Solvent to Dissolve Drug and Reagents. To
dissolve MPM, acetonitrile was preferred to chloroform,
dichloromethane, acetone, 2-propanol, 1,2-dichloroethane,
1,4-dioxane, methanol, and ethanol because as the complex
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Figure 2: Eﬀect of reagents concentration on color development:
(1) p-CA (0.5%) using 200μgmL −1 MPM, and (2) DDQ (0.25%)
using 40μgmL −1 MPM.
formed in these solvents either had very low absorbance
values or precipitated upon dilution, whereas in the case,
of reagents, highly intense-coloured products were formed
when 1,4-dioxane medium was maintained as solvent to
dissolve p-CA and DDQ. Therefore, acetonitrile and 1,4-
dioxane were chosen as solvents to dissolve MPM and the
reagents, respectively.
3.2.3. Eﬀect of Reaction Time and Stability of the C-T Com-
plexes. The optimum reaction times were determined by
measuring the absorbance of the formed complex upon the
addition of reagent solution to MPM solution at room tem-4 Journal of Analytical Methods in Chemistry
Table 1: Sensitivity and regression parameters of the proposed methods in comparison with the reported UV-spectrophotometric methods
[10].
Parameter p-CA method DDQ method 0.1N HCl method Acetate buﬀer method
λmax, nm 520 580 250 250
Color stability 5h 20min — —
Linear range, μgmL −1 40–400 6–120 10–30 10–30
Molar absorptivity (ε),
Lmol −1cm−1 1.06 × 103 3.87 × 103 NR∗∗∗ NR
Sandell sensitivity∗, μgcm −2 0.4106 0.1119 NR NR
Limit of detection (LOD),
μgmL −1 3.96 0.79 NR NR
Limit of quantiﬁcation (LOQ),
μgmL −1 11.99 2.40 NR NR
Regression equation, Y∗∗
Intercept (a) 0.0100 0.0376 0.00316 0.01547
Slope (b) 0.0024 0.0080 0.02201 0.02168
Standard deviation of y-axis (Sy) 0.0118 0.0416 — —
Standard deviation of a (Sa) 0.0145 0.0350 — —
Standard deviation of b (Sb)5 . 3 × 10−5 4.75 × 10−4 ——
Correlation coeﬃcient (r) 0.9995 0.9947 0.9999 0.9996
∗L i m i to fd e t e r m i n a t i o na st h ew e i g h ti nμg per mL of solution, which corresponds to an absorbance of A = 0.001 measured in a cuvette of cross-sectional
area 1cm2 and l = 1cm. ∗∗Y = a+bX,w h e r eY is the absorbance, X is concentration in μg/mL, a is intercept, and b is slope. ∗∗∗NR: not reported.
Table 2: Evaluation of intraday and interday accuracy and precision.
Method MPM taken,
μgm L −1
Intraday accuracy and precision (n = 7) Interday accuracy and precision (n = 5)
MPM found,
μgm L −1 %RE %RSD MPM found,
μgm L −1 %RE %RSD
A
100.0 100.63 0.63 0.66 101.26 1.26 1.14
200.0 200.22 0.11 0.36 201.28 0.64 0.78
300.0 306.96 2.32 0.99 305.34 1.78 1.28
B
45.00 43.84 2.58 0.50 45.75 1.67 0.74
75.00 76.04 1.39 0.87 76.69 2.25 1.36
105.0 108.02 2.88 0.92 101.81 3.04 1.78
%RE: percent relative error; %RSD: relative standard deviation.
Table 3: Method robustness and ruggedness expressed as intermediate precision (%RSD).
Method MPM taken,
μgmL −1
Robustness Ruggedness
Parameters altered Interanalysts
(%RSD), (n = 4)
Interinstruments
(%RSD), (n = 4) Volume of
p-CA/DDQ∗
Reaction
timeΨ
A
100.0 0.94 0.58 1.28 2.42
200.0 1.36 0.65 0.84 3.15
300.0 1.27 0.42 0.85 2.76
B
45.0 0.66 0.36 0.96 1.98
75.0 0.74 0.85 0.78 2.38
105.0 1.03 0.64 0.54 1.62
∗The volumes of p-CA or DDQ added were 1 ± 0.2.
ΨThe reaction times were 5 ± 1min.Journal of Analytical Methods in Chemistry 5
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Figure 3: Eﬀect of reaction time.
Table 4:ResultsofanalysisofCellCept500tabletsΨ bytheproposed
methods and statistical comparison of the results with the reference
method.
Nominal amount
(mg/tablet)
Found∗ (percent of label claim ± SD)
Reference
method p-CA method DDQ method
101.0 ±1.16 99.89 ±1.74
500 100.6 ±0.76 t = 0.66 t = 0.89
F = 2.33 F = 5.24
∗Mean value of 5 determinations.
Tabulated t-value at the 95% conﬁdence level and for four degrees of
freedom is 2.77.
Tabulated F-value at the 95% conﬁdence level and for four degrees of
freedom is 6.39.
ΨMarketed by Sun pharmaceuticals.
perature (Figure 3). In both methods, the formation of C-
T complex was completed within 5min and the absorbance
values of the measured species were stable for 5h and 20min
for p-CA and DDQ methods, respectively.
3.3. Investigation of Composition of C-T Complexes. The
composition of the C-T complexes with either p-CA or
DDQ was evaluated by following Job’s continuous variations
method [21]. The experiments were performed by preparing
and mixing equimolar solutions of drug and reagent (p-
CA method: 4.61 × 10−4M MPM and p-CA; DDQ method:
2.31 × 10−4M) by maintaining the total volume at 2.5mL.
The plots of the molar ratio between drug and reagent
versus the absorbance values were prepared (Figures 4(a) and
4(b)), and the results revealed that the formation of C-T
complex between drug and reagent followed a 1:1 reaction
stoichiometry. This ﬁnding was anticipated by the presence
of one basic electron donating center (nitrogen atom) in the
MPM structure. Based on this fact, the following reaction
pathway for the formation of C-T complex is proposed and
shown in Scheme 1. The conditional stability constants (Kf)
of the charge transfer complexes were calculated [22]f r o m
the data of continuous variations method and found to be
9.46 × 106 and 7.48 × 105 for MPM-p-CA and MPM-DDQ
complexes, respectively.
3.4. Association Constants and Free Energy Change. The ab-
sorbances of MPM-p-CA and MPM-DDQ complexes can be
used to calculate the association constant using the Benesi-
Hildebrand equation which depends on the experimental
condition that one of the two component species should be
present in large excess, so that its concentration is virtually
unaltered on formation of the C-T complex.
In this study, the donor-acceptor systems were studied
within a limited range of concentration. The acceptor con-
centrations were not low enough to be considered negligible
with respect to donor concentration; the Ross and Labes
equation was therefore used to calculate the association con-
stant of the charge transfer complexes [23]:
[A][D]
[A]+[D]
×
1
Aλ
=
1
Kελ
×
1
[A]+[D]
+
1
ελ
,( 2 )
where [A]a n d[ D] refer to the molar concentration of ac-
ceptor and donor, respectively, Aλ is the absorbance at the
wavelength λ,a n dK and ελ are the association constant
and molar absorptivity, respectively. The association con-
stants (K) for MPM-p-CA and MPM-DDQ complexes were
calculated and found to be 1.096 × 104 and 1.117 × 104,
respectively.
The standard free energy change of the complexation
(ΔG0) was calculated from the association constant (K)v a l -
ues according to the following well-established equation:
ΔG0 =− 2.303RT logK,( 3 )
where ΔG0 is the standard free energy of the C-T com-
plex (kJmol−1), R is the gas constant (8.314Jmol−1K−1),
and T is the absolute temperature (298.15K). The stan-
dard free energy change was calculated to be −23.06 and
−23.11kJmol−1 for MPM-p-CA and MPM-DDQ com-
plexes, respectively.
3.5. Method Validation
3.5.1. Linearity, Sensitivity, Limits of Detection, and Quantiﬁ-
cation. A linear correlation was found between absorbance
at λmax and concentration of MPM in the ranges given in
Table 1. Regression analysis of Beer’s law data using the
method of least squares was made to evaluate the slope
(b), intercept (a), standard deviations of y-axis, slope and
intercept, and correlation coeﬃcient (r) for each system and
thevaluesarepresentedinTable 1.Theopticalcharacteristics
such as Beer’s law limits, molar absorptivity, and Sandell
sensitivity values [24] of both methods are also given in
Table 1. The limits of detection (LOD) and quantitation
(LOQ) calculated according to ICH guidelines [25] are also
presented in Table 1.T h em o d e r a t ev a l u e so fε and Sandell
sensitivity and LOD indicate the sensitivity of the proposed
methods.6 Journal of Analytical Methods in Chemistry
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Figure 4: Job’s plots obtained for (a) 4.61 × 10−4M MPM and p-CA C-T complex and (b) 2.31 × 10−4 M MPM and DDQ C-T complex.
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3.5.2. Precision and Accuracy. The assays described under the
constructionofcalibrationscurveswererepeatedseventimes
within the day to determine the intraday precision and ﬁve
timesondiﬀerentdays to determine the interday precision of
the methods. These assays were performed for three levels of
analyte. The results of this study are summarized in Table 2.
The percentage relative standard deviation (%RSD) values
were ≤0.99% (intraday) and ≤1.78% (interday) indicating
high precision of the methods. Accuracy was evaluated as
percentage relative error (%RE) between the measured mean
concentrations and taken concentrations for MPM. The
percentagerelativeerrorwascalculatedateachconcentration
and these results are also presented in Table 2.P e r c e n t
relativeerror(%RE)valuesof ≤3.04%demonstratesthehigh
accuracy of the proposed methods.
3.5.3. Selectivity. The results obtained from placebo blank
and synthetic mixture analyses revealed that the inactive
ingredients used in the preparation did not interfere in the
assay of active ingredient. The absorbance values obtained
from the placebo blank solution were almost equal to the
absorbance of the blank which revealed no interference from
the adjuvants. To study the role of additives added to the
synthetic sample, 3mL of the resulting solution prepared
using synthetic mixture (500 and 150μgmL −1 in MPM from
p-CA method and DDQ method) was assayed (n = 4).
The percentage recoveries of 97.63–106.1 with %RSD values
in the range 1.22–1.85 demonstrated the accuracy as well
as the precision of the proposed methods and complement
the ﬁndings of the placebo blank analysis with respect to
selectivity.
3.5.4. Robustness and Ruggedness. The robustness of the
methodswasevaluatedbymakingsmallincrementalchanges
in the volume of reagent and contact time, and the eﬀect of
the changes was studied on the absorbance of the measuredJournal of Analytical Methods in Chemistry 7
Table 5: Results of recovery study via standard-addition method with CellCept 500.
p-CA method DDQ method
MPM in tablet,
μgmL −1
Pure MPM
added, μgmL −1
Total found,
μgmL −1
Pure MPM
recovered
(Percent ± SD∗)
MPM in tablet,
μgmL −1
Pure MPM
added, μgmL −1
Total found,
μgmL −1
Pure MPM
recovered
(Percent ± SD)
101.0 50.0 152.8 103.6 ±0.74 40.0 20.0 59.47 97.37 ±0.76
101.0 100.0 202.5 101.5 ±0.86 40.0 40.0 80.60 101.5 ±1.08
101.0 150.0 249.1 98.74 ±0.92 40.0 60.0 102.46 104.1 ±0.84
∗Mean value of three determinations.
species. The changes had negligible inﬂuence on the results
as revealed by small intermediate precision values expressed
as %RSD (≤1.36%). Method ruggedness was demonstrated
having the analysis done by four analysts and also by a single
analyst performing analysis on four diﬀerent instruments in
the same laboratory. Intermediate precision values (%RSD)
in both instances were in the range 0.54–3.15% indicating
acceptable ruggedness. The results are presented in Table 3.
3.5.5. Application. The proposed methods were applied to
the quantiﬁcation of MPM in commercially available Cell-
Cept 500 tablets. The results obtained were compared with
thoseobtainedusingareferencenonaqueouspotentiometric
method [26] which is an oﬃcial potentiometric titration of
MPM with 0.1M perchloric acid in anhydrous acetic acid
medium. Statistical analysis of the results did not detect any
signiﬁcant diﬀerence in the performance of the proposed
methodtothereferencemethodwithrespecttoaccuracyand
precision as revealed by the Student’s t-value and variance
ratio F-value [27]. The results of this study are given in Table
4.
3.5.6. Recovery Study. To further assess the accuracy of
the proposed methods, recovery experiment was performed
by applying the standard-addition technique. The recovery
was assessed by determining the agreement between the
measured standard concentration and added known concen-
tration to the sample. The test was done by spiking the pre-
analyzed tablet powder with pure MPM at three diﬀerent
levels (50, 100, and 150%, of the content present in the tablet
powder (taken) and the total was found by the proposed
method. Each test was repeated three times. From this test,
the percentage recovery values were found in the range of
97.37–104.1 with standard deviation values from 0.74 to
1.08%. Closeness of the results to 100% showed the fairly
good accuracy of the proposed methods. These results are
shown in Table 5.
4. Conclusions
Two simple, moderately sensitive, extraction-free, rapid, and
cost-eﬀective spectrophotometric methods based on charge
transfer complex formation reaction were developed and
validated for the determination of MPM. The reagents
utilized in the proposed methods are cheap, readily available,
and the procedure does not involve any critical reaction
conditions or tedious sample preparation. The proposed
methods are characterized by the wide linear dynamic ranges
relative to narrow ranges (10–30μgmL −1)o ft h er e p o r t e d
UV-spectrophotometric methods [10]. Also, the proposed
methods are subject to no interference since the measure-
ments are made at 520 and 580nm compared to the reported
methods [10] where the absorbance is measured at 250nm
and the chances of interferences from inactive ingredients
are more there by aﬀecting the accuracy of the results.
The statistical parameters and the recovery data reveal good
accuracy and precision of the methods. These methods can
beused asgeneralmethods forthedetermination of MPMin
bulkpowderandtablets.Themethodshavemanyadvantages
over the separation techniques such as HPLC and include
reduced cost and speed with high accuracy. Hence, the
methods can be used in routine analysis of drug in quality
control laboratories.
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